Skip to main content
Premium Trial:

Request an Annual Quote

Networked Is Slightly Different Than Networking

At Thus Spake Zuska, Suzanne Franks outlines what's being called the age of Networked Science, as opposed to Big Science and Team Science of years past.  She wonders if it will, in the end, be good for scientists. "Call me cynical, but I'm just thinking that an arrangement which saves companies the expense of having to actually 'hire researchers to meet all [their] rapidly evolving scientific needs' cannot possibly be in the best long-term interests of the scientists themselves," she writes, of an article that appeared in this week's The Chronicle of Higher Education.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.